研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

针对癌症幸存者的造口术远程医疗干预的随机前瞻性试验。

A randomized prospective trial of an ostomy telehealth intervention for cancer survivors.

发表日期:2023 Oct 31
作者: Robert S Krouse, Siqi Zhang, Christopher S Wendel, Virginia Sun, Marcia Grant, Elizabeth Ercolano, Mark C Hornbrook, Zuleyha Cidav, Ariel Nehemiah, Matthew Rock, Scott Appel, Judith H Hibbard, Michael J Holcomb
来源: CANCER

摘要:

接受造口术的癌症幸存者面临着复杂的挑战。这项研究比较了造口自我管理远程医疗计划 (OSMT) 与注意力控制常规护理 (UC)。三个学术中心对参与者进行了随机分组。 OSMT 小组会议由造口护士和同伴造口者主持(三场仅用于造口者,一场用于支持人员,一场针对两者的审查会议)。基线、OSMT 完成和 6 个月时的调查主要结果为患者激活 (PAM)、自我效能 (SE)、希望之城造口生活质量 (COH-O) 以及医院焦虑和抑郁量表 (HADS)。根据指南对至少完成两项调查的人员进行调查评分。使用线性混合效应模型为最终模型选择潜在的协变量,并测试每个时间范围内 OSMT 的影响。总共 90 个 OSMT 和 101 个 UC 满足分析标准。手臂匹配良好,但肿瘤类型分布不均匀 (p = .023)。 6 个月时,OSMT 组的 PAM 没有显着改善(置信区间 [CI],-3.65 至 5.3];4.0 与 2.9)。其他调查没有显着差异。 OSMT 对泌尿系肿瘤(四个 SE 域)有显着的益处。 OSMT 会议出席率较高与五个 SE 领域 (p < .05)、两个 COH-O 领域 (p < .05) 和 HADS 焦虑 (p = .01) 的会后改善相关。 6 个月时,一个 SE 域 (p < .05)、一个 COH-O 域 (p < .05) 和 HADS 焦虑 (p < .01) 仍有改善。OSMT 干预没有明显的益处,尽管根据肿瘤类型可能有优势。更多的会议出席率带来的好处也令人鼓舞。造口的癌症患者面临许多挑战。我们测试了远程医疗课程与常规护理的比较。有迹象表明,该计划对于参加更多课程和接受尿路造口术的患者有益。© 2023 美国癌症协会。
Cancer survivors with ostomies face complex challenges. This study compared the Ostomy Self-Management Telehealth program (OSMT) versus attention control usual care (UC).Three academic centers randomized participants. OSMT group sessions were led by ostomy nurses and peer ostomates (three for ostomates-only, one for support persons, and one review session for both). Surveys at baseline, OSMT completion, and 6 months were primary outcome patient activation (PAM), self-efficacy (SE), City of Hope quality of life-Ostomy (COH-O), and Hospital Anxiety and Depression Scale (HADS). Surveys were scored per guidelines for those completing at least two surveys. Linear mixed effects models were used to select potential covariates for the final model and to test the impact of OSMT within each timeframe.A total of 90 OSMT and 101 UC fulfilled analysis criteria. Arms were well-matched but types of tumors were unevenly distributed (p = .023). The OSMT arm had a nonsignificant improvement in PAM (confidence interval [CI], -3.65 to 5.3]; 4.0 vs. 2.9) at 6 months. There were no significant differences in other surveys. There was a significant OSMT benefit for urinary tumors (four SE domains). Higher OSMT session attendance was associated with post-session improvements in five SE domains (p < .05), two COH-O domains (p < .05), and HADS anxiety (p = .01). At 6 months, there remained improvements in one SE domain (p < .05), one COH-O domain (p < .05), and HADS anxiety (p < .01).No clear benefit was seen for the OSMT intervention, although there may be an advantage based on type of tumor. Benefit with greater session attendance was also encouraging.Cancer patients with ostomies have many challenges. We tested a telehealth curriculum compared to usual care. There are indications of benefit for the program for those that attend more sessions and those with urostomies.© 2023 American Cancer Society.